vTv Therapeutics
VTVT
18 hedge funds and large institutions have $1.48M invested in vTv Therapeutics in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
43% more capital invested
Capital invested by funds: $1.04M → $1.48M (+$444K)
0.21% more ownership
Funds ownership: 2.15% → 2.36% (+0.21%)
5% less funds holding
Funds holding: 19 → 18 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$195K |
| 2 |
Barclays
London,
United Kingdom
|
+$194K |
| 3 |
Two Sigma Investments
New York
|
+$134K |
| 4 |
Renaissance Technologies
New York
|
+$58.7K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$24.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$119K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$107K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$39K |
| 4 |
Goldman Sachs
New York
|
-$17K |
| 5 |
Millennium Management
New York
|
-$16K |
VTVT Hedge Fund Activity: Q4 2019 in Review
18 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q4 2019, worth a combined $1.48M — up 43% from $1.04M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VTVT and 5 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Bank of America, adding an estimated $195K. The largest seller was Virtu Financial, exiting entirely with an estimated $119K sold.
- 18 institutional investors held vTv Therapeutics (VTVT) as of Q4 2019, down from 19 in Q3 2019.
- Funds reported $1.48M of vTv Therapeutics stock for Q4 2019, up 43% quarter-over-quarter.
- 5 funds opened new vTv Therapeutics positions in Q4 2019 and 6 closed out, a net change of -1 holder.
- The largest vTv Therapeutics buyer in Q4 2019 was Bank of America, an estimated $195K added.
- The largest vTv Therapeutics seller in Q4 2019 was Virtu Financial, an estimated $119K sold.
Based on aggregated 13F filings for Q4 2019.